YAKHAK HOEJI

Table. 1.

Table 1 Detailed information of adverse event related to weight loss in United States Food and Drug administration adverse events reporting system database

	Preferred Term	Lowest Level Term
Lipid-lowering Adverse events	Blood cholesterol decreased High density lipoprotein decreased Hypo HDL cholesterolaemia Hypocholesterolaemia Low density lipoprotein decreased Non-high-density lipoprotein cholesterol decreased Very low density lipoprotein decreased Total cholesterol/HDL ratio decreased Ldl/hdl ratio decreased Hypolipidaemia Lipids decreased Blood triglycerides decreased Hypotriglyceridaemia	Blood cholesterol decreased Cholesterol blood decreased Cholesterol blood lowered Cholesterol blood reduced Cholesterol levels low Cholesterol low Cholesterol total decreased HDL cholesterol decreased High density lipoprotein cholesterol decreased High density lipoprotein cholesterol low Hypo HDL cholesterolaemia Hypo HDL cholesterolemia Hypocholesterolaemia Hypocholesterolemia Low density lipoprotein cholesterol decreased Low density lipoprotein cholesterol low Non-HDL cholesterol decreased Non-high-density lipoprotein cholesterol decreased Very low density lipoprotein cholesterol decreased Very low density lipoprotein cholesterol low Total cholesterol/HDL ratio decreased Ldl/hdl ratio decreased Hypolipidaemia Lipids decreased Blood triglycerides decreased Hypotriglyceridemia Triglyceride decreased Triglycerides decreased Triglycerides low
Weight loss Adverse events	Abnormal loss of weight Underweight Weight decreased	Abnormal loss of weight Loss of weight Lost weight Underweight Weight decrease Weight decreased Weight loss

Yakhak Hoeji 2024;68:362-70 https://doi.org/10.17480/psk.2024.68.5.362